According to the announcement of Xingqi Pharmaceutical, the company cancelled 2.405 million shares, accounting for 0.67% of the total share capital before cancellation, involving an amount of about 100 million yuan. After review, the cancellation of the repurchased shares took effect on August 7, 2026. After the cancellation was completed, the total share capital of the company was reduced from 357 million shares to 355 million shares. The cancellation of this share repurchase will not have a significant impact on the company, and related work such as changes in registered capital will be handled in the future.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.